Tag Archives: Pfizer Inc

Zoetis™ Declares Second-Quarter 2013 Dividend

By Business Wirevia The Motley Fool

Filed under:


Zoetis™ Declares Second-Quarter 2013 Dividend

MADISON, N.J.–(BUSINESS WIRE)– The Board of Directors of ZoetisTM (NYS: ZTS) , formerly the animal health business of Pfizer Inc., has declared a second-quarter dividend payable to holders of the company’s Class A common stock and Class B common stock of $0.065 per share. The dividend is to be paid on June 6, 2013, to holders of record on May 1, 2013.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. The company generated annual revenues of $4.3 billion in 2012. It has more than 9,300 employees worldwide and a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.


DISCLOSURE NOTICE
: This news release contains forward-looking statements, which reflect Zoetis’ current views with respect to business plans or prospects, future operating or financial performance, and other future events. These statements are not guarantees of future performance. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors”, and in our reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov or on request from Zoetis.

<div …read more
Source: FULL ARTICLE at DailyFinance

Zoetis™ to Host Webcast and Conference Call on First-Quarter 2013 Financial Results

By Business Wirevia The Motley Fool

Filed under:


Zoetis™ to Host Webcast and Conference Call on First-Quarter 2013 Financial Results

MADISON, N.J.–(BUSINESS WIRE)– ZoetisTM (NYS: ZTS) , formerly the animal health business of Pfizer Inc., will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, April 30, 2013. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Rick Passov will review first-quarter 2013 financial results, discuss 2013 financial guidance, and respond to questions from financial analysts during the call.

Investors and the public may access the live webcast by visiting the Zoetis website at http://www.zoetis.com/events-and-presentations. Information on accessing and pre-registering for the webcast is available beginning today. A replay of the webcast will be archived and made available on April 30.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. The company generated annual revenues of $4.2 billion in 2011. It had approximately 9,500 employees and a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.


DISCLOSURE NOTICE
: This news release contains forward-looking statements, which reflect Zoetis’ current views with respect to business plans or prospects, future operating or financial performance, and other future events. These statements are not guarantees of future performance. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of these risks, uncertainties and other factors can be found in Zoetis’ Registration Statement on Form S-1 (File No. 333-183254), as amended, …read more
Source: FULL ARTICLE at DailyFinance

Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts

By Business Wirevia The Motley Fool

Filed under:

Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts

NEW YORK–(BUSINESS WIRE)– Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, April 30, 2013. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s First Quarter 2013 Performance Report, to be issued that morning.

To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com and click on the “Pfizer Quarterly Corporate Performance – First Quarter 2013″ link in the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today. Participants are advised to pre-register in advance of the conference call.

You can also listen to the conference call by dialing either (866) 246-2545 in the United States and Canada or (706) 634-2365 outside of the United States and Canada. The password is “First Quarter Earnings”.

Visitors to www.pfizer.com will be able to view and listen to an archived copy of the webcast of the conference call.

Pfizer Inc.
Media Relations
Joan Campion, 212-733-2798
or
Investor Relations
Suzanne Harnett, 212-733-8009

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:

The article Pfizer Invites Public to View and Listen to Webcast of April 30 Conference Call with Analysts originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, …read more
Source: FULL ARTICLE at DailyFinance

Corporate Cash Piles Up

By 24/7 Wall St.

Money, US, $100 bills

Filed under:

The debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that forecasts how big the cash balances will be at some of these public corporations at the end of 2013.

The kind of activism Apple Inc. (NASDAQ: AAPL) has faced about distributing its cash to shareholders through a higher dividend or share buybacks almost certainly will spread to the other companies on the Moody’s list.

The Moody’s report put Apple’s year-end cash balance at $170 billion. Microsoft Corp. (NASDAQ: MSFT), Google Inc. (NASDAQ: GOOG), Pfizer Inc. (NYSE: PFE) and Cisco Systems Inc. (NASDAQ: CSCO) are also on the Moody’s list. Perhaps the most critical difference between these companies and Apple is that they have shown a history of acquisitions. Apple has never used its money that way, at least on any large scale.

According to MarketWatch:

Overall, corporate-cash stockpiles at U.S. non-financial companies rated by Moody’s grew to $1.45 trillion in 2012, up 10% from 2011, according to the report.

Filed under: 24/7 Wall St. Wire, Dividends & Buybacks Tagged: AAPL, CSCO, GOOG, MSFT, PFE

Read | Permalink | Email this | Linking Blogs | Comments

…read more
Source: FULL ARTICLE at DailyFinance

What's Important in the Financial World (3/19/3013)

By 24/7 Wall St.

Garden gnomes

Filed under:

Corporate Cash Piles Up

The debate over how America’s largest companies use cash will pick up again. Moody’s Investor Services released a study that forecasts how big the cash balances will be at some of these public corporations at the end of 2013. The kind of activism Apple Inc. (NASDAQ: AAPL) has faced about distributing its cash to shareholders through a higher dividend or share buybacks almost certainly will spread to the other companies on the Moody’s list. The Moody’s report put Apple’s year-end cash balance at $170 billion. Microsoft Corp. (NASDAQ: MSFT), Google Inc. (NASDAQ: GOOG), Pfizer Inc. (NYSE: PFE) and Cisco Systems Inc. (NASDAQ: CSCO) are also on the Moody’s list. Perhaps the most critical difference between these companies and Apple is that they have shown a history of acquisitions. Apple has never used its money that way, at least on any large scale. According to MarketWatch:

Overall, corporate-cash stockpiles at U.S. non-financial companies rated by Moody’s grew to $1.45 trillion in 2012, up 10% from 2011, according to the report.

Cypriot Parliament to Weigh In

The parliament in Cyprus may block the government‘s attempt to seize money from the savings accounts of its citizens as a way to raise money to get access to bailout funds. If so, the anxiety about the action, and its possible effects on the plans of other financially weak EU nations, should drop. Some analysts believe there could be a sort of contagion, if countries like Greece run out of options to close budget gaps. Cyprus does not have anywhere else to turn for the money, which is the primary reason it took such measures. According to Reuters:

Cyprus‘s parliament is unlikely to pass legislation taxing deposits which has prompted turmoil in its banking system, falling short on a condition for an international bailout, government spokesman Christos Stylianides said on Tuesday.

Apple and Its Shadow

Wherever Apple Inc. (NASDAQ: AAPL) goes, Samsung is never far behind it. The South Korean company said it will build and market a smartwatch, just as Apple is rumored to be doing. Among a heightened competition, the launches are likely to cause another round of intellectual property and patent challenges in courts around the world. These kinds of fights already are well along as Samsung has challenged both the iPhone and the iPad. According to Bloomberg:

“We’ve been preparing the watch product for so long,” Lee Young Hee, executive vice president of Samsung’s mobile business, said during an interview in Seoul. “We are working very hard to get ready for it. We are preparing products for the future, and the watch is definitely one of them.”

Filed under: 24/7 Wall St. Wire, Market Open Tagged: AAPL, CSCO, GOOG, MSFT, PFE

Read | Permalink | Email this | Linking Blogs | Comments

…read more
Source: FULL ARTICLE at DailyFinance

Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick

By DividendChannel.comA study of analyst recommendations at the major brokerages shows that Pfizer Inc (NYSE: PFE) is the #2 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Pfizer Inc is also a top tier analyst pick among the broader S&P 500 index components, claiming the #22 spot out of 500.
Source: Forbes Markets